Budesonide News
Budesonide currently has 1 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Budesonide with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Jorveza is indicated for the treatment of eosinophilic esophagitis (EoE) in adults (older than 18 years of age).
- Evidence level: L5
- Predicted indications (20):
- atopic eczema (100.0%)
- allergic asthma (99.9%)
- intrinsic asthma (99.9%)
- bronchitis (99.8%)
- dermatitis, atopic (99.8%)
- polyp of vocal cord (99.7%)
- polyp of middle ear (99.7%)
- epulis (99.7%)
- fibroepithelial polyp (99.7%)
- uterine polyp (99.7%)
- polyp of frontal sinus (99.7%)
- polyp of external auditory canal (99.7%)
- polyp of vulva (99.7%)
- polyp of ureter (99.7%)
- neoplastic polyp (99.7%)
- 2-hydroxyethyl methacrylate sensitization (99.6%)
- asthma (99.5%)
- Crohn's colitis (99.3%)
- inflammatory bowel disease (99.2%)
- anus disease (99.0%)
Related News (1)
Vous êtes fatigué en ce début d’automne ? C’est normal mais vous pouvez y remédier - Le HuffPost
2026-10-10 EPOC
Source: Le HuffPost
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.